Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component (CROSBI ID 311298)

Prilog u časopisu | Pismo uredniku | međunarodna recenzija

(Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and the Tuberculosis Network European Trials group (TBnet) Guglielmetti, Lorenzo ; Günther, Gunar ; Leu, Claude ; Cirillo, Daniela ; Duarte, Raquel ; Garcia-Basteiro, Alberto L. ; Goletti, Delia ; Janković, Mateja ; Kuksa, Liga ; Maurer, Florian P. et al. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component // The European respiratory journal, 59 (2022), 5; 2200388, 3. doi: 10.1183/13993003.00388-2022

Podaci o odgovornosti

Guglielmetti, Lorenzo ; Günther, Gunar ; Leu, Claude ; Cirillo, Daniela ; Duarte, Raquel ; Garcia-Basteiro, Alberto L. ; Goletti, Delia ; Janković, Mateja ; Kuksa, Liga ; Maurer, Florian P. ; Méchaï, Frédéric ; Tiberi, Simon ; van Leth, Frank ; Veziris, Nicolas ; Lange, Christoph

Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and the Tuberculosis Network European Trials group (TBnet

engleski

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Lack of access to rifapentine in Europe denies patients optimal care for active tuberculosis and latent tuberculosis infection, and deprives healthcare providers of adequate tools to pursue tuberculosis control and elimination

rifapentine, tuberculosis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

59 (5)

2022.

2200388

3

objavljeno

0903-1936

1399-3003

10.1183/13993003.00388-2022

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost